Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated (VRTX)

Market Closed
6 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
502. 31
-1.19
-0.2363%
$
133.69B Market Cap
30.83 P/E Ratio
- Div Yield
775,057 Volume
14.94 Eps
$ 503.5
Previous Close
Add Transaction
Day Range
496.25 506.59
Year Range
400.86 560.25
Want to track VRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Vertex Pharmaceuticals Incorporated Investors

Name Quantity Cost Value Profit ($) Gain (%)
Provenance Wealth Advisors LLC
Provenance Wealth Advisors LLC Provenance Wealth Advisors LLC
10 $4,967 $5,025.85 $58.85 1.18%
Michael Behner
Michael Behner Nautilus Advisors LLC
777 $363,256.57 $389,844.21 $26,587.64 7.32%
TGI
Torrey Growth & Income Advisors Torrey Growth & Income Advisors
4,710 $1.84M $2.34M $497,187.6 26.95%
United Financial Planning Group LLC
United Financial Planning Group LLC United Financial Planning Group LLC
14 $6,258.55 $7,042.7 $784.15 12.53%
BML
Berman McAleer LLC Berman McAleer LLC
574 $226,591.34 $288,750.7 $62,159.36 27.43%
Jon Borer
Jon Borer Capitolis Liquid Global Markets LLC
26,249 $12.28M $13.2M $921,988.89 7.51%
Jesper Lorenzen
Jesper Lorenzen Danica Pension Livsforsikringsaktieselskab
27,829 $12.51M $13.95M $1.44M 11.48%
WMA
William Mack & Associates Inc. William Mack & Associates Inc.
630 $253,700.63 $315,768.6 $62,067.97 24.47%